NCT04223245

Brief Summary

People with Parkinson Disease (PWPD) have significant problems with velocity, safety and dual tasking during walking that may be secondary to poor automaticity. Sensory functions, especially visual dependence and proprioceptive integration are critical for efficient walking and are often impaired. This home program compares the use of multimodal sensory feedback during stepping and balance exercises in PWPD to a group without the sensory feedback performing the same basic exercises.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Jun 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 29, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 17, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

December 2, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 10, 2020

Completed
Last Updated

January 10, 2020

Status Verified

January 1, 2020

Enrollment Period

1.3 years

First QC Date

December 2, 2019

Last Update Submit

January 7, 2020

Conditions

Keywords

multimodalreal-time feedbackautomaticitygaitbalance

Outcome Measures

Primary Outcomes (4)

  • Changes in temporalspatial components of Gait

    temporal and spacial components of gait measured with Gaitrite Mat

    baseline before exercise training, 6 weeks, 12 weeks and 18 weeks after initiation of exercise

  • changes in balance

    single leg stance time, time standing on foam eyes closed, Mini-BESTest

    baseline before exercise training, 6 weeks, 12 weeks and 18 weeks after initiation of exercise

  • Change in cognitive attention needed for gait

    3 meter walk test performed at comfortable gait speed once and repeated while subtracting 3s from 100 to assess cognitive attention needed for walking tasks (automaticity)

    Baseline, 6 weeks, 12 weeks and 18 weeks after initiation of exercise

  • Change in perceived difficulty during gait and ADLs,

    Parkinson Disease Questionnaire (PDQ-39)

    Baseline, 6 weeks, 12 weeks and 18 weeks after initiation of exercise

Study Arms (2)

exercise+MMSF

EXPERIMENTAL

Group of PWPD who performed a base exercise program of speed and large amplitude stepping and standing balance exercises with Multimodal real-time sensory feedback

Behavioral: exercise+multi-modal sensory feedback (MMSF)

exercise only

ACTIVE COMPARATOR

Group PWPD who did the same exercise program without MMSF

Behavioral: Exercise only

Interventions

home program of 3 stepping exercises and 3 balance exercises with progression of speed, step distance and reduced vision. Real-time sensory feedback during ex. using ankle, wrist wts., laser on chest and mat with footpads and clickers (auditory feedback during stepping)

exercise+MMSF
Exercise onlyBEHAVIORAL

3 stepping and 3 balance exercises which are to progress in speed and distance of movement as well as progress to eyes closed while performing.

exercise only

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Medical diagnosis of Parkinson Disease
  • A score of 26 or higher on the Mini-Mental Status Exam
  • Able to stand from sitting and take 5 steps without assistance
  • People who have been on the same dosages of medication for PD for 3 weeks or longer

You may not qualify if:

  • Participating in an exercise program for less than 3 months
  • Plans to change a current exercise program during the study
  • Changes in medications that affect PD or its sequelea

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regis University

Denver, Colorado, 80221, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Patricia A Winkler, PT, DSc

    Regis University, 3333 Regis Blvd , Denver, Co 80221

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
blinded to subject group assignment
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single blind randomized trial with 2 groups
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2019

First Posted

January 10, 2020

Study Start

June 29, 2017

Primary Completion

October 17, 2018

Study Completion

March 8, 2019

Last Updated

January 10, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations